Professor of Neurology, Oregon Hlth and Sci Univ
Neurology
Dr. Helmi L. Lutsep, MD
|
|
Give Review
Helmi Lutsep works in the field of Neurology. She graduated from Mayo Medical School. Mayo Medical School is ranked 27 in research and 42 in primary care medicine She received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Portland Monthly Magazine" and "Men's Health". Helmi L. Lutsep, MD is a published doctor and has 78 publications published. The lastest was: 'Modular organization of cognitive systems masked by interhemispheric integration.' Helmi Lutsep accepts all Medicare patients.
Publications
- Long-Term Follow-up to a Randomized Controlled Trial Comparing Peroneal Nerve Functional Electrical Stimulation to an Ankle Foot Orthosis for Patients With Chronic Str...
- The Year Embolectomy Won: a Review of Five Trials Assessing the Efficacy of Mechanical Intervention in Acute Stroke.
- Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?
- Outcome in Patients Previously on Antithrombotic Therapy in the SAMMPRIS Trial: Subgroup Analysis.
- Epidural Electrical Stimulation for Stroke Rehabilitation: Results of the Prospective, Multicenter, Randomized, Single-Blinded Everest Trial.
- Predictors of Functional Dependence Despite Successful Revascularization in Large-Vessel Occlusion Strokes.
- Serial Alberta Stroke Program Early CT Score From Baseline to 24 Hours in Solitaire Flow Restoration With the Intention for Thrombectomy Study: A Novel Surrogate End P...
- Association of Intraprocedural Blood Pressure and End Tidal Carbon Dioxide with Outcome After Acute Stroke Intervention.
- Aggressive medical treatment with or without stenting in high-risk patients with intracranial Artery stenosis (SAMMPRIS): the final results of a randomised trial.
- THRIVE Score Predicts Outcomes With a Third-Generation Endovascular Stroke Treatment Device in the TREVO-2 Trial.
- Medical and lifestyle interventions, not procedures, should be the primary focus in stroke prevention.
- New stent retriever devices.
- Dabigatran etexilate: management in acute ischemic stroke.
- Neurologic safety event rates in the SENTIS trial control population.
- Endovascular mechanical thrombectomy for the treatment of acute ischemic stroke due to arterial dissection.
- Effects of Sex on Mechanical Embolectomy Outcome.
- Indications and applications of arterial stents for stroke prevention in atherosclerotic intracranial stenosis.
- Does sex matter? Thirty-day stroke and death rates after Carotid artery stenting in women versus men: results from the Carotid Revascularization Endarterectomy versus ...
- Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings.
- Vertebrobasilar revascularization rates and outcomes in the MERCI and multi-MERCI trials.
- Motor cortex stimulation for the enhancement of recovery from stroke: a prospective, multicenter safety study.
- Stroke treatment and prevention are not the same in men and women.
- New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
- MATCH results: implications for the internist.
- Use of functional MRI to guide decisions in a clinical stroke trial.
- Current status of hemorrhagic stroke and acute nonthrombolytic ischemic stroke treatment.
- The era of the device in ischemic stroke.
- Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study.
- Intraarterial suction thrombectomy in acute stroke.
- Emergi-paths and stroke teams: an emergency department approach to acute ischemic stroke.
- Localizing acute stroke-related EEG changes: assessing the effects of spatial undersampling.
- An update of neuroprotectants in clinical development for acute stroke.
- Efficacy of intraarterial thrombolysis of basilar Artery stroke.
- The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis.
- Risk factors associated with major Cerebrovascular complications after intracranial stenting.
- Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the EC...
- Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke.
- Assisted movement with enhanced sensation (AMES): coupling motor and sensory to remediate motor deficits in chronic stroke patients.
- Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience.
- Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization.
- Motor cortex stimulation for enhancement of recovery after stroke: case report.
- Association of intracranial stenosis with cortical symptoms or signs.
- Neuroprotection in acute ischaemic stroke. Current status and future potential.
- AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Ma...
- Medical treatment strategies: intravenous thrombolysis, neuronal protection, and anti-reperfusion injury agents.
- Clinical acute stroke evaluation.
- Modular organization of cognitive Systems masked by interhemispheric integration.
- Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke.
- Use of fluid attenuating inversion recovery, MR angiogram, and diffusion-weighted MRI techniques for assessment of pontine infarction in a patient treated with radiati...
- Cerebral and callosal organisation in a right hemisphere dominant "split Brain" patient.
- Ultrastructural, morphometric, and immunocytochemical study of anterior horn cells in mice with "wasted" mutation.
- Potential of anticytokine therapies in Central nervous system ischaemia.
- Does reversal of ischemia on diffusion-weighted imaging reflect higher apparent diffusion coefficient values?
- Mapping individual Brains to guide restorative therapy after stroke: rationale and pilot studies.
- Plasma total homocysteine levels in stroke patients screened for the vitamin intervention for stroke prevention clinical trial in the era of folate fortification.
- Thrombolysis in young adults.
- The therapeutic potential of anti-cytokine strategies in Central nervous system ischaemia.
- Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial.
- Repinotan, A 5-HT1A agonist, in the treatment of acute ischemic stroke.
- Thrombolytic and newer mechanical device treatment for acute ischemic stroke.
- Benign angioedema after thrombolysis for acute stroke.
- Open label tissue plasminogen activator for stroke: the Oregon experience.
- GABA agonist: clomethiazole.
- Repinotan Bayer.
- Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial.
- Current status of neuroprotective agents in the treatment of acute ischemic stroke.
- Mechanical endovascular recanalization therapies.
- Mechanical endovascular acute stroke treatment: here to stay.
- Higher degrees of recanalization after mechanical thrombectomy for acute stroke are associated with improved outcome and decreased mortality: pooled analysis of the ME...
- Stenting versus aggressive medical therapy for intracranial arterial stenosis.
- Drug eluting stents for symptomatic intracranial and vertebral Artery stenosis.
- A focus on stroke in women.
- Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).
- Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral Artery occlusion.
- Mechanical thrombectomy for the treatment of acute ischemic stroke.
- Symptomatic intracranial stenosis: best medical treatment vs. intracranial stenting.
- Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Associa...
Schools
Mayo Med School
Mayo Grad School Med
Stanford University Med Center
University Of California Davis
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Bell's Palsy
- View All
Doctors Specialties
- Vascular Neurology
- Neurology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Portland Monthly Magazine
- Men's Health
Education
-
Mayo School of Graduate Medical Education -
Mayo Medical School
Drug Facts
| NPI NUMBER | 1164437661 | |
| NPPES Provider LastName | LUTSEP | |
| NPPES Provider FirstName | HELMI | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Neurology | |
| Total Claim Count | 67.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164437661 |
| Last Name Of The Provider | LUTSEP |
| First Name Of The Provider | HELMI |
| View All |
Similar Doctors
|
|
Dr. Logan M. McDaneld, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ted Lowenkopf, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wayne M. Clark, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erek K. Helseth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Noah C. Beadell, MD |
|
|
Dr. Kimmy G. Su, MD
This Doctor is OpenDoctor Recommended.
|